Petition Closed

The availability of these drugs donepezil; rivastigmine; galantamine; and memantine are vital to people suffering from dementia and Alzheimer's disease. They are specifically designed for dementia to slow down progression of the disease, as well as ease symptoms. If these drugs are removed from the Pharmaceutical Benefits Scheme (PBS) it will make it very expensive (up to $150 a month) for people to access these medications. We need to be a voice for those unable to speak and keep these medications on the PBS.

This petition was delivered to:
  • The Pharmaceutical Benefits Advisory Committee


    Kerri Cross started this petition with a single signature, and now has 148 supporters. Start a petition today to change something you care about.